Jesus Garcia-Foncillas is currently the Director of the University Cancer Institute and the Department of Oncology at the University Hospital “Fundacion Jimenez Diaz” (Autonomous University of Madrid, Spain), Professor of Oncology at the Autonomous University of Madrid, and director of the Professorship on Molecular Individualized Medicine Autonomous University-Merck. He combines this with the roles of Director of the Translational Oncology Division at the Health Research Institute FJD-UAM (Autonomous University of Madrid) and Chairman of the Comprehensive Cancer Program of four University Hospitals at Madrid (Fundacion Jimenez Diaz University Hospital, Infanta Elena University Hospital, Rey Juan Carlos University Hospital and Villalba University General Hospital).
Prof Garcia-Foncillas obtained his MD from the School of Medicine, University of Zaragoza (Zaragoza, Spain) and was awarded PhD from the University of Navarra (Pamplona, Spain). He was subsequently awarded a fellowship in medical oncology at the University Clinic of Navarre.
Prof. Garcia-Foncillas has directed his scientific endeavors towards applying basic research to cancer diagnosis and treatment. He has holded several positions both nationally and internationally, such as Vice-President for the National Medical Oncology Commission, Ministry of Health, Council on Medical Specialties, President of the Tenth National Congress sponsored by the Spanish Cancer Research Association, President of the V Meeting of the Spanish Society of Pharmacogenomics and Pharmacogenetics, Co-coordinator of the Genomics and Proteomics Program at the Network of Cancer Centers (Carlos III Health Institute); Board Member for the Spanish Group on Hereditary Cancer, Board Member for the Spanish Federation of Oncology Associations (FESEO). Furthermore, he is a correspondent academician for the Royal Spanish Academy at Zaragoza since 1998 and Honorary Member of the Mexican Oncology Association since 2005. Additionally, Prof. Garcia-Foncillas is trustee of the Olga Torres Foundation, Merck Salud Foundation and Foundation for the Excellence and Quality in Oncology (ECO), Coordinator and Scientific Director of the OncoDNA Advisory Committee. and President of the Mediterranean Oncology Society (MOS, 2012-2016). He has recently awarded with the 2014-Prize to the best Spanish Researcher Oncologist (“A Tu Salud” Research Award). Professor García-Foncillas has been awarded the 2020 National Prize of the Royal National Academy of Medicine of Spain, being elected as member of the same institution and has also been distinguished as the best researcher in Oncology 2020 (“La Razón” Award).
Prof. Garcia-Foncillas is conducting many clinical trials from phase-1 to phase-3, he is author of more than 275 articles (PubMed) and several books on Cancer.
